Management expects net sales to be in the range of $342 to $348 million, gross margin to be approximately 52.5% to 54.5% and adjusted earnings per share in the range of $0.01 to $0.06 as it continues to invest in new product launches to drive future growth.
Hims & Hers Health Q2 EPS $(0.10) Misses $(0.09) Estimate, Sales $113.60M Beat $103.88M Estimate
Hims & Hers Health (NYSE:HIMS) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 100 percent decrease over losses of $(0.05) per share from
